Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems


  • - General Urology - Common Urological Problems - Medical Renal Disease
  • Jul 29, 2010
  • Comments
  • Viewed: 8973
Tags: | focal glomerulosclerosis | glomerulonephritis | hematuria | immunologic mechanisms |

The clinical manifestations of glomerular renal disease are apt to consist only of varying degrees of hematuria, excretion of characteristic formed elements in the urine,  proteinuria,  and renal insufficiency and its complications.

Excluding diabetes, purported immunologic renal diseases are the most common cause of proteinuria and the nephrotic syndrome.

Alterations in glomerular architecture as observed in tissue examined by light microscopy alone can be minimal, nonspecific,  and difficult to interpret.  For these reasons, specific diagnoses of renal disease require targeted immune fluorescent techniques for demonstrating a variety of antigens,  antibodies,  and complement fractions.  Electron microscopy has complemented these immunologic methods. Tissue analysis can be assisted by blood tests of immunoglobulins (Ig),  complement,  and other mediators of inflammation.

The 2 important humoral mechanisms leading to deposition of antibodies within the glomerulus are based on the location of the antigen,  whether fixed within the kidney or present in soluble form in circulation. The fixed antigens are either a natural structural element of the glomerulus or foreign materials that have been trapped within the glomerulus for a variety of immunologic or physiochemical reasons.  The best examples of the fixed natural antigens are those associated with the glomerular basement membrane (GBM).  These antigens are evenly distributed in the GBM and cause characteristic linear IgG deposition, as determined in immunofluorescence studies.

This process represents 5% of cases of immune-mediated glomerular disease and is referred to as anti-GBM disease.

Diagnosis of Medical Renal Disease

Medical Renal Disease

However, most patients with glomerular immune deposits have discontinuous immune aggregates caused by antibody binding to native renal cell antigens or to antigens trapped within the glomerulus. In addition, immune complexes formed in the circulation can deposit and accumulate in the GBM and the mesangium.

A group of immune-mediated nephritides characterized by necrotizing and crescentic architecture and rapid progression are referred to as pauci-immune glomerular nephritides because, while antibodies may contribute to the pathogenesis of the disease,  they are rarely demonstrated within the glomeruli.  These are known as antineutrophil cytoplasmic antibody (ANCA)  diseases.  Circulating antibodies against myeloperoxidase, MPO (P-ANCA) and proteinase 3, PR3 (C-ANCA) have been noted in microscopic angiitis and Wegener’s granulomatosis, respectively.

Cellular immune processes are likely to be stimulated and contribute in different ways in various other forms of glomerulonephritides.

The current classification of glomerulonephritis is based on the mechanism, the presence, and the localization of immune aggregates in the glomeruli.

Immunologic Mechanisms Likely
1.  Glomerulonephritis associated with postinfectious glomerulonephritis such as poststreptococcal glomerulonephritis
2.  Membranous nephropathy idiopathic or secondary to other causes such as systemic lupus erythematosus, cancer, gold penicillamine

1.  Glomerulonephritis associated with systemic lupus erythematosus,  type I idiopathic membranoproliferative glomerulonephritis (MPGN), glomerulonephritis associated with hepatitis C infection, bacterial endocarditis, and shunt nephritis

1.  IgA nephropathy, Schönlein-Henoch purpura

1.  Diffuse linear deposition of Ig

Immunologic Mechanisms Not Clearly Established
1.  Minimal change nephropathy
2.  Focal glomerulosclerosis
3.  Hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura
4.  ANCA-associated disease: Wegener’s granulomatosis and small-vessel vasculitis
5.  Type II MPGN (dense deposit disease)

Flavio G. Vincenti, MD, & William J.C. Amend, Jr., MD


  1. Adler S: Diabetic nephropathy: Linking histology, cell biology, and genetics. Kidney Int 2004;66:2095.
  2. Alric L et al: Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN. Am J Kidney Dis 2004;43:617.
  3. Appel GB et al: Membranoproliferative glomerulonephritis Type II (dense deposit disease): An update. J Amer Soc Neph 2005;16: 1392.
  4. Barratt J, Feehally J: IgA nephropathy. J Amer Soc Neph 2005;16: 2088.
  5. Braden GL et al: Tubulointerstitial diseases. Am J Kidney Dis 2005; 46:560.
  6. Buhaescu I et al: Systemic vasculitis: Still a challenging disease. Am J Kidney Dis 2005;46:173.
  7. Chesney R: The changing face of childhood nephrotic syndrome. Kidney Int 2004;66:1294.
  8. Flanc RS et al: Treatment of diffuse proliferative lupus nephritis: A meta-analysis of randomized controlled trials. Am J Kidney Dis 2004;43:197.
  9. Couser WG (guest editor): Frontiers in nephrology: Membranous nephropathy. J Amer Soc Neph 2005;16:1184.
  10. Ginzler EM et al: Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 2005;353:2219.
  11. Grantham JJ: Advancement in the understanding of polycystic kidney disease: A system approach. Kidney Int 2003;64: 1154.
  12. Heering P et al: Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis. Am J Kidney Dis 2004;43:10.
  13. Hruska KA: Treatment of chronic tubulointerstitial disease: A new concept. Kidney Int 2002;61:1911.
  14. Imaging the Kidney-Radiologic Imaging 2006. (Excerpts) Nephron Clin Pract 2006;103:c19.
  15. Izzedine H et al: Oculorenal manifestations in systemic autoimmune diseases. Am J Kidney Dis 2004;43:209.
  16. Javaid B, Quigg RJ: Treatment of glomerulonephritis: Will we ever have options other than steroids and cytotoxics? Kidney Int 2005;67:1692.
  17. Nair R, Walker PD: Is IgA nephropathy the commonest primary glomerulopathy among young adults in the USA? Kidney Int 2006;69:1455.
  18. Noris M, Remuzzi G: Hemolytic uremic syndrome. J Amer Soc Neph 2005;16:1035.
  19. Perna A et al: Immunosuppressive treatment for idiopathic membranous nephropathy: A systematic review. Am J Kidney Disease 2004;44:385.
  20. Rosner MH, Bolton WK: Renal function testing. Am J Kidney Dis 2006;47:174.
  21. Rossert J: Drug-induced acute interstitial nephritis. Kidney Int 2001; 60:804.
  22. Tenenhouse HS, Murer H: Disorders of renal tubular phosphate transport. J Am Soc Neph 2003;14:240.
  23. Troyanov S et al: Renal pathology in idiopathic membranous nephropathy: A new perspective. Kidney Int 2006;69:1641.
  24. Wilmer WA et al: Management of glomerular proteinuria: A commentary. J Amer Soc Neph 2003;14:3217.

Bookmark and Share

Post a comment [ + Comment here + ]

There are no comments for this entry yet. [ + Comment here + ]

Your details

* Required field

Please enter the word you see in the image below:

Comments are moderated by our editors, so there may be a delay between submission and publication of your comment. Offensive or abusive comments will not be published.

recurrent tumors1 - urine7 - lpp4 - bladder discomfort1 - nephropathy3 - intrauterine devices1 - outlet obstruction6 - denosumab1 - urge urinary incontinence5 - kidney tumours1 - urinary tract problems1 - de toni-fanconi-debré syndrome1 - alport disease1 - renal cancer2 - urine incontinence1 - ectopic pregnancy2 - clear cell rcc1 - abdominopelvic cavity1 - bulbocavernosus reflex1 - radiological society of north america1 - physician1 - renal medulla1 - urinary citrate1 - pkd2 - local recurrence1 - metastatic1 - boston university school of medicine1 - advanced prostate cancer8 - pten1 - metanephros1 -